Skip to contentN
Neogenomics Inc
N
NEONeogenomics Inc Q4 2018 · 10-K
Revenue$76.48M$76.48M+24.5% vs Q4 2017 Net Income$353.00K$353.00K−92.2% vs Q4 2017 EPS Diluted$0.00$0.00−100.0% vs Q4 2017 Gross Profit$37,111,000+38.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
derived
Operating Cash Flowderived$15,453,000+168.3% Free Cash Flowderived$12,234,000+447.1% Margins · derivedGross margin48.5%+5.0 pt vs Q4 2017
Operating margin3.7%−2.3 pt vs Q4 2017
Net margin0.5%−6.9 pt vs Q4 2017
ended Dec 31, 2018 · filed Feb 26, 2019 · 57 d after period end